Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene therapy for heart failure and cardiomyopathies.

Revista espanola de cardiologia (English ed.) - 1 Dec 2023

Argirò Alessia, Ding Jeffrey, Adler Eric

Abstract excerpt

Gene therapy strategies encompass a range of approaches, including gene replacement and gene editing. Gene replacement involves providing a functional copy of a modified gene, while gene editing allows for the correction of existing genetic mutations. Gene therapy has already received approval for treating genetic disorders like Leber's congenital amaurosis and spinal muscular atrophy. Currently, research is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathies
Share to CRISPR and Genetic Engineering
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Heart Failure

Share to Leber Congenital Amaurosis

Share to Mutation

Share to Viral Infections and Immunology Research

Share to Virus-based gene therapy research

Source

Identifiers

PMID: 37506969
DOI: 10.1016/j.rec.2023.06.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene therapy for heart failure and cardiomyopathies.PMID 37506969Read ↗

State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesSemantic proximity Read ↗

Gene therapy for cardiac diseases: methods, challenges, and future directions.Semantic proximity Read ↗

Unveiling the Future of Cardiac Care: A Review of Gene Therapy in CardiomyopathiesSemantic proximity Read ↗

Human Cardiac Gene TherapySemantic proximity Read ↗

Gene therapy for heart failureSemantic proximity Read ↗

Applications of Gene Therapy in CardiomyopathiesSemantic proximity Read ↗

Gene Therapy for Inherited Cardiac Arrhythmias.Semantic proximity Read ↗

Gene Therapy in Cardiovascular Disease: Recent Advances and Future Directions in Science: A Science Advisory From the American Heart AssociationSemantic proximity Read ↗

Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophySemantic proximity Read ↗

Gene Therapy in Cardiology: Is a Cure for Hypertrophic Cardiomyopathy on the Horizon?Semantic proximity Read ↗

Gene Therapy in the Treatment of Heart FailureSemantic proximity Read ↗

Gene therapy for the treatment of heart failure: promise postponedSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.